DHR vs MEDP
Danaher Corporation vs Medpace — AI-powered side-by-side comparison
DHR
Danaher Corporation
63
Buy
VS
| Metric | DHR | MEDP |
|---|
| AI Score |
63
|
65
|
| Price |
$204.80
|
$590.35
|
| P/E Ratio |
36.24×
|
33.97×
|
| ROE |
6.9%
|
98.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
58.5%
|
28.8%
|
| Debt / Equity |
0.51×
|
0.28×
|
| Dividend Yield |
0.7%
|
0.0%
|
| RSI (14) |
67.2
|
64.4
|
| Beta |
0.823
|
1.151
|
| Expected Upside |
+1.6%
|
+5.5%
|
AI Committee View
Current Innellis committee reasoning for DHR versus MEDP.
MEDP leads by 2 points.
MEDP scores 65/100 (Buy) versus DHR at 63/100 (Buy).
DHR Committee View
80% agreement
5 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is p/e of 35.9 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 35.9 is moderate-to-rich — Value
MEDP Committee View
67% agreement
6 analysts
The primary driver is eps growing 26.8% yoy. The main limiting factor is p/e of 33.5 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 110.1% shows genuine earnings power backing the valuation — Value
- EPS growing 26.8% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
Bear Case
- P/E of 33.5 is moderate-to-rich — Value
- Price-to-book of 34.5x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical